Claudia Filozof M.D.

Claudia Filozof MD PhD is an accomplished medical professional with extensive experience in the fields of obesity, hepatology, and metabolic disorders. Currently serving as Vice President and Therapeutic Area Head for Fortrea since May 2023, Claudia also holds a position as a Scientific Advisory Board member at MetaSight Diagnostics. Previously, Claudia was Vice President and Liver Therapeutic Area Head at Labcorp Drug Development from July 2019 to June 2023, and Executive Medical Director in Clinical Development at Covance from August 2014 to June 2019, focusing on NAFLD/NASH. As a Global Clinical Indication Leader at Novartis from November 2008 to August 2014, Claudia led initiatives in severe hypertriglyceridemia and NAFLD, including the development of Medical Affairs strategies. Earlier experience includes serving as European Medical Director for Metabolics at Bristol-Myers Squibb from October 2004 to October 2008. Claudia Filozof earned an MD PhD in Nutrition and Metabolism from Buenos Aires University.